Stocktoria
ATOSSA THERAPEUTICS, INC. ATOS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-11-08
ATOSSA THERAPEUTICS, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expense | $21.2M | $14.1M | $17.3M | $15.1M | $9.2M | $6.6M | $6.6M | $4.2M | $2.3M | $770,427 |
| Operating income | -$37.1M | -$27.6M | -$31.4M | -$27.7M | -$20.5M | -$14.6M | -$17.3M | -$11.4M | -$7.6M | -$8.0M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$34.8M | -$25.5M | -$30.1M | -$27.0M | -$20.6M | -$17.8M | -$17.2M | -$11.4M | -$8.1M | -$6.4M |
| EPS (diluted) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | — | — | — | — | — | — |
| Operating cash flow | -$29.8M | -$21.0M | -$20.9M | -$20.8M | -$16.5M | -$11.6M | -$9.1M | -$9.0M | -$6.6M | -$5.4M |
| Free cash flow | -$29.8M | -$21.0M | -$21.0M | -$20.8M | -$16.5M | -$11.6M | -$9.1M | -$9.1M | — | — |
| Cash & equivalents | $41.3M | $71.1M | $88.5M | $110.9M | $136.4M | $39.6M | $12.6M | $10.4M | $7.2M | $3.0M |
| Total assets | $47.6M | $76.4M | $96.3M | $123.5M | $141.3M | $42.8M | $14.5M | $11.7M | $8.2M | $4.1M |
| Total liabilities | $8.3M | $5.0M | $5.2M | $5.6M | $3.1M | $15.7M | $1.3M | $2.9M | — | $1.0M |
| Shareholders' equity | $39.4M | $71.5M | $91.0M | $118.0M | $138.1M | $27.2M | $13.2M | $8.8M | $6.9M | $3.1M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.